+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Clinical Trial Supplies Market 2024-2028

  • PDF Icon

    Report

  • 175 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 5120713
1h Free Analyst Time

Growing Demand for CROS is a Key Trend Gaining Market Momentum

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical trial supplies market is forecasted to grow by USD 1.31 billion during 2023-2028, accelerating at a CAGR of 8.65% during the forecast period. The report on the clinical trial supplies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of biopharmaceutical industry, government initiatives on clinical research, and regulation of clinical trials in regional markets.

The clinical trial supplies market is segmented as below:

By End-user

  • Pharmaceutical industry
  • Biologics industry
  • Medical device industry

By Type

  • Phase III
  • Phase II
  • Phase IV and BE/BA studies
  • Phase I

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing demand for cros as one of the prime reasons driving the clinical trial supplies market growth during the next few years. Also, increase in studies focusing on pharmaceutical industry and rising demand for e-clinical trials will lead to sizable demand in the market.

The report on the clinical trial supplies market covers the following areas:

  • Clinical trial supplies market sizing
  • Clinical trial supplies market forecast
  • Clinical trial supplies market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trial supplies market vendors that include Ancillare LP, Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc., Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PCI Pharma Services, PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Precision Medicine Group LLC, Thermo Fisher Scientific Inc., and Vertical Pharma Resources Ltd.. Also, the clinical trial supplies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Clinical Trial Supplies Market 2018 - 2022
Historic Market Size - Data Table on Global Clinical Trial Supplies Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Pharmaceutical industry - Market size and forecast 2023-2028
Chart on Pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
Data Table on Pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
Chart on Pharmaceutical industry - Year-over-year growth 2023-2028 (%)
Data Table on Pharmaceutical industry - Year-over-year growth 2023-2028 (%)
6.4 Biologics industry - Market size and forecast 2023-2028
Chart on Biologics industry - Market size and forecast 2023-2028 ($ million)
Data Table on Biologics industry - Market size and forecast 2023-2028 ($ million)
Chart on Biologics industry - Year-over-year growth 2023-2028 (%)
Data Table on Biologics industry - Year-over-year growth 2023-2028 (%)
6.5 Medical device industry - Market size and forecast 2023-2028
Chart on Medical device industry - Market size and forecast 2023-2028 ($ million)
Data Table on Medical device industry - Market size and forecast 2023-2028 ($ million)
Chart on Medical device industry - Year-over-year growth 2023-2028 (%)
Data Table on Medical device industry - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Phase III - Market size and forecast 2023-2028
Chart on Phase III - Market size and forecast 2023-2028 ($ million)
Data Table on Phase III - Market size and forecast 2023-2028 ($ million)
Chart on Phase III - Year-over-year growth 2023-2028 (%)
Data Table on Phase III - Year-over-year growth 2023-2028 (%)
7.4 Phase II - Market size and forecast 2023-2028
Chart on Phase II - Market size and forecast 2023-2028 ($ million)
Data Table on Phase II - Market size and forecast 2023-2028 ($ million)
Chart on Phase II - Year-over-year growth 2023-2028 (%)
Data Table on Phase II - Year-over-year growth 2023-2028 (%)
7.5 Phase IV and BE/BA studies - Market size and forecast 2023-2028
Chart on Phase IV and BE/BA studies - Market size and forecast 2023-2028 ($ million)
Data Table on Phase IV and BE/BA studies - Market size and forecast 2023-2028 ($ million)
Chart on Phase IV and BE/BA studies - Year-over-year growth 2023-2028 (%)
Data Table on Phase IV and BE/BA studies - Year-over-year growth 2023-2028 (%)
7.6 Phase I - Market size and forecast 2023-2028
Chart on Phase I - Market size and forecast 2023-2028 ($ million)
Data Table on Phase I - Market size and forecast 2023-2028 ($ million)
Chart on Phase I - Year-over-year growth 2023-2028 (%)
Data Table on Phase I - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Ancillare LP
Ancillare LP - Overview
Ancillare LP - Product / Service
Ancillare LP - Key offerings
12.4 Avantor Inc.
Avantor Inc. - Overview
Avantor Inc. - Business segments
Avantor Inc. - Key news
Avantor Inc. - Key offerings
Avantor Inc. - Segment focus
12.5 Bushu Pharmaceuticals Ltd.
Bushu Pharmaceuticals Ltd. - Overview
Bushu Pharmaceuticals Ltd. - Product / Service
Bushu Pharmaceuticals Ltd. - Key offerings
12.6 Clinigen Group Plc
Clinigen Group Plc - Overview
Clinigen Group Plc - Product / Service
Clinigen Group Plc - Key offerings
12.7 Deutsche Bahn AG
Deutsche Bahn AG - Overview
Deutsche Bahn AG - Product / Service
Deutsche Bahn AG - Key offerings
12.8 Emsere B.V
Emsere B.V - Overview
Emsere B.V - Product / Service
Emsere B.V - Key offerings
12.9 International Bonded Couriers Inc.
International Bonded Couriers Inc. - Overview
International Bonded Couriers Inc. - Product / Service
International Bonded Couriers Inc. - Key offerings
12.10 Nuvisan GmbH
Nuvisan GmbH - Overview
Nuvisan GmbH - Product / Service
Nuvisan GmbH - Key offerings
12.11 Obvio Health USA Inc.
Obvio Health USA Inc. - Overview
Obvio Health USA Inc. - Product / Service
Obvio Health USA Inc. - Key offerings
12.12 Parexel International Corp.
Parexel International Corp. - Overview
Parexel International Corp. - Product / Service
Parexel International Corp. - Key offerings
12.13 PCI Pharma Services
PCI Pharma Services - Overview
PCI Pharma Services - Product / Service
PCI Pharma Services - Key offerings
12.14 PHOENIX Pharmahandel GmbH and Co KG
PHOENIX Pharmahandel GmbH and Co KG - Overview
PHOENIX Pharmahandel GmbH and Co KG - Product / Service
PHOENIX Pharmahandel GmbH and Co KG - Key news
PHOENIX Pharmahandel GmbH and Co KG - Key offerings
12.15 Piramal Enterprises Ltd.
Piramal Enterprises Ltd. - Overview
Piramal Enterprises Ltd. - Product / Service
Piramal Enterprises Ltd. - Key offerings
12.16 Precision Medicine Group LLC
Precision Medicine Group LLC - Overview
Precision Medicine Group LLC - Product / Service
Precision Medicine Group LLC - Key offerings
12.17 Vertical Pharma Resources Ltd.
Vertical Pharma Resources Ltd. - Overview
Vertical Pharma Resources Ltd. - Product / Service
Vertical Pharma Resources Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Clinical Trial Supplies Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on End-user - Market share 2023-2028 (%)
Exhibits 33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by End-user
Exhibits 35: Data Table on Comparison by End-user
Exhibits 36: Chart on Pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Pharmaceutical industry - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Pharmaceutical industry - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Pharmaceutical industry - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Biologics industry - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Biologics industry - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Biologics industry - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Biologics industry - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Medical device industry - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Medical device industry - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Medical device industry - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Medical device industry - Year-over-year growth 2023-2028 (%)
Exhibits 48: Market opportunity by End-user ($ million)
Exhibits 49: Data Table on Market opportunity by End-user ($ million)
Exhibits 50: Chart on Type - Market share 2023-2028 (%)
Exhibits 51: Data Table on Type - Market share 2023-2028 (%)
Exhibits 52: Chart on Comparison by Type
Exhibits 53: Data Table on Comparison by Type
Exhibits 54: Chart on Phase III - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Phase III - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Phase III - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Phase III - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Phase II - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Phase II - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Phase II - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Phase II - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Phase IV and BE/BA studies - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Phase IV and BE/BA studies - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Phase IV and BE/BA studies - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Phase IV and BE/BA studies - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Phase I - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Phase I - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Phase I - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Phase I - Year-over-year growth 2023-2028 (%)
Exhibits 70: Market opportunity by Type ($ million)
Exhibits 71: Data Table on Market opportunity by Type ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 113: Market opportunity By Geographical Landscape($ million)
Exhibits 114: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits 115: Impact of drivers and challenges in 2023 and 2028
Exhibits 116: Overview on criticality of inputs and factors of differentiation
Exhibits 117: Overview on factors of disruption
Exhibits 118: Impact of key risks on business
Exhibits 119: Companies covered
Exhibits 120: Matrix on companies position and classification
Exhibits 121: Ancillare LP - Overview
Exhibits 122: Ancillare LP - Product / Service
Exhibits 123: Ancillare LP - Key offerings
Exhibits 124: Avantor Inc. - Overview
Exhibits 125: Avantor Inc. - Business segments
Exhibits 126: Avantor Inc. - Key news
Exhibits 127: Avantor Inc. - Key offerings
Exhibits 128: Avantor Inc. - Segment focus
Exhibits 129: Bushu Pharmaceuticals Ltd. - Overview
Exhibits 130: Bushu Pharmaceuticals Ltd. - Product / Service
Exhibits 131: Bushu Pharmaceuticals Ltd. - Key offerings
Exhibits 132: Clinigen Group Plc - Overview
Exhibits 133: Clinigen Group Plc - Product / Service
Exhibits 134: Clinigen Group Plc - Key offerings
Exhibits 135: Deutsche Bahn AG - Overview
Exhibits 136: Deutsche Bahn AG - Product / Service
Exhibits 137: Deutsche Bahn AG - Key offerings
Exhibits 138: Emsere B.V - Overview
Exhibits 139: Emsere B.V - Product / Service
Exhibits 140: Emsere B.V - Key offerings
Exhibits 141: International Bonded Couriers Inc. - Overview
Exhibits 142: International Bonded Couriers Inc. - Product / Service
Exhibits 143: International Bonded Couriers Inc. - Key offerings
Exhibits 144: Nuvisan GmbH - Overview
Exhibits 145: Nuvisan GmbH - Product / Service
Exhibits 146: Nuvisan GmbH - Key offerings
Exhibits 147: Obvio Health USA Inc. - Overview
Exhibits 148: Obvio Health USA Inc. - Product / Service
Exhibits 149: Obvio Health USA Inc. - Key offerings
Exhibits 150: Parexel International Corp. - Overview
Exhibits 151: Parexel International Corp. - Product / Service
Exhibits 152: Parexel International Corp. - Key offerings
Exhibits 153: PCI Pharma Services - Overview
Exhibits 154: PCI Pharma Services - Product / Service
Exhibits 155: PCI Pharma Services - Key offerings
Exhibits 156: PHOENIX Pharmahandel GmbH and Co KG - Overview
Exhibits 157: PHOENIX Pharmahandel GmbH and Co KG - Product / Service
Exhibits 158: PHOENIX Pharmahandel GmbH and Co KG - Key news
Exhibits 159: PHOENIX Pharmahandel GmbH and Co KG - Key offerings
Exhibits 160: Piramal Enterprises Ltd. - Overview
Exhibits 161: Piramal Enterprises Ltd. - Product / Service
Exhibits 162: Piramal Enterprises Ltd. - Key offerings
Exhibits 163: Precision Medicine Group LLC - Overview
Exhibits 164: Precision Medicine Group LLC - Product / Service
Exhibits 165: Precision Medicine Group LLC - Key offerings
Exhibits 166: Vertical Pharma Resources Ltd. - Overview
Exhibits 167: Vertical Pharma Resources Ltd. - Product / Service
Exhibits 168: Vertical Pharma Resources Ltd. - Key offerings
Exhibits 169: Inclusions checklist
Exhibits 170: Exclusions checklist
Exhibits 171: Currency conversion rates for US$
Exhibits 172: Research methodology
Exhibits 173: Information sources
Exhibits 174: Data validation
Exhibits 175: Validation techniques employed for market sizing
Exhibits 176: Data synthesis
Exhibits 177: 360 degree market analysis
Exhibits 178: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global clinical trial supplies market: Ancillare LP, Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc., Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PCI Pharma Services, PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Precision Medicine Group LLC, Thermo Fisher Scientific Inc., and Vertical Pharma Resources Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing demand for cros."

According to the report, one of the major drivers for this market is the growth of biopharmaceutical industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ancillare LP
  • Avantor Inc.
  • Bionical Emas Group
  • Bushu Pharmaceuticals Ltd.
  • Catalent Inc.
  • Clinical Services International Ltd.
  • Clinigen Group Plc
  • Deutsche Bahn AG
  • Emsere B.V
  • GNH India Pharmaceuticals Ltd.
  • International Bonded Couriers Inc.
  • Nuvisan GmbH
  • Obvio Health USA Inc.
  • Parexel International Corp.
  • PCI Pharma Services
  • PHOENIX Pharmahandel GmbH and Co KG
  • Piramal Enterprises Ltd.
  • Precision Medicine Group LLC
  • Thermo Fisher Scientific Inc.
  • Vertical Pharma Resources Ltd.